Published in J Virol on July 01, 2004
Type I IFN enhances follicular B cell contribution to the T cell-independent antibody response. J Exp Med (2010) 1.54
Early B-cell activation after West Nile virus infection requires alpha/beta interferon but not antigen receptor signaling. J Virol (2008) 1.35
In celiac disease, a subset of autoantibodies against transglutaminase binds toll-like receptor 4 and induces activation of monocytes. PLoS Med (2006) 1.34
C-reactive protein inhibits cholesterol efflux from human macrophage-derived foam cells. Arterioscler Thromb Vasc Biol (2007) 1.00
Plasmacytoid dendritic cells promote rotavirus-induced human and murine B cell responses. J Clin Invest (2013) 0.94
Host response to probiotics determined by nutritional status of rotavirus-infected neonatal mice. J Pediatr Gastroenterol Nutr (2012) 0.93
Innate immune responses to human rotavirus in the neonatal gnotobiotic piglet disease model. Immunology (2010) 0.89
Rotavirus differentially infects and polyclonally stimulates human B cells depending on their differentiation state and tissue of origin. J Virol (2010) 0.86
Division of labor during primary humoral immunity. Immunol Res (2013) 0.83
In silico study of rotavirus VP7 surface accessible conserved regions for antiviral drug/vaccine design. PLoS One (2012) 0.81
Rotavirus infection enhances lipopolysaccharide-induced intussusception in a mouse model. J Virol (2006) 0.80
Comparison of probiotic lactobacilli and bifidobacteria effects, immune responses and rotavirus vaccines and infection in different host species. Vet Immunol Immunopathol (2016) 0.79
Rotavirus activates lymphocytes from non-obese diabetic mice by triggering toll-like receptor 7 signaling and interferon production in plasmacytoid dendritic cells. PLoS Pathog (2014) 0.78
Recombinant outer capsid glycoprotein (VP7) of rotavirus expressed in insect cells induces neutralizing antibodies in rabbits. Iran J Public Health (2012) 0.76
The improvement effects of edible bird's nest on proliferation and activation of B lymphocyte and its antagonistic effects on immunosuppression induced by cyclophosphamide. Drug Des Devel Ther (2016) 0.75
Lack of evidence of rotavirus-dependent molecular mimicry as a trigger of coeliac disease. Clin Exp Immunol (2016) 0.75
Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis (2003) 9.44
Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein. J Virol (1992) 8.35
Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol (2000) 7.78
Serological analysis of the subgroup protein of rotavirus, using monoclonal antibodies. Infect Immun (1983) 5.85
Three-dimensional structure of rotavirus. J Mol Biol (1988) 3.79
Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity. Science (1996) 3.07
Hemagglutinin protein of wild-type measles virus activates toll-like receptor 2 signaling. J Virol (2002) 2.86
Three-dimensional structure of rhesus rotavirus by cryoelectron microscopy and image reconstruction. J Cell Biol (1990) 2.83
Murine retroviruses activate B cells via interaction with toll-like receptor 4. Proc Natl Acad Sci U S A (2002) 2.70
Characterization of virus-like particles produced by the expression of rotavirus capsid proteins in insect cells. J Virol (1994) 2.48
Antigenic comparisons of two new rotaviruses from rhesus monkeys. J Clin Microbiol (1980) 2.39
T cell stimulation in vivo by lipopolysaccharide (LPS). J Exp Med (1997) 2.29
Functional and topographical analyses of epitopes on the hemagglutinin (VP4) of the simian rotavirus SA11. J Virol (1988) 2.08
Role of B cells and cytotoxic T lymphocytes in clearance of and immunity to rotavirus infection in mice. J Virol (1995) 2.06
Comparison of mucosal and systemic humoral immune responses and subsequent protection in mice orally inoculated with a homologous or a heterologous rotavirus. J Virol (1994) 2.03
Rotavirus virus-like particles administered mucosally induce protective immunity. J Virol (1997) 1.96
CD14 and innate recognition of bacteria. J Immunol (1995) 1.78
The epidemiology of rotavirus diarrhea in the United States: surveillance and estimates of disease burden. J Infect Dis (1996) 1.73
Development of an adult mouse model for studies on protection against rotavirus. J Virol (1990) 1.72
Non-antigen-specific B-cell activation following murine gammaherpesvirus infection is CD4 independent in vitro but CD4 dependent in vivo. J Virol (1999) 1.71
Trypsin cleavage stabilizes the rotavirus VP4 spike. J Virol (2001) 1.68
T helper cell-independent neutralizing B cell response against vesicular stomatitis virus: role of antigen patterns in B cell induction? Eur J Immunol (1995) 1.65
Inhibition of the mitogenic response to lipopolysaccharide (LPS) in mouse spleen cells by polymyxin B. J Immunol (1977) 1.57
Heterogeneity in the structural glycoprotein (VP7) of simian rotavirus SA11. Virology (1982) 1.47
Immunity to rotavirus in T cell deficient mice. Virology (1997) 1.47
The type-specific capsular carbohydrate of Hemophilus influenzae B is a potent mitogen for murine B lymphocytes. J Immunol (1986) 1.42
Single-cell perforin and granzyme expression reveals the anatomical localization of effector CD8+ T cells in influenza virus-infected mice. Proc Natl Acad Sci U S A (2003) 1.39
Localization of rotavirus VP4 neutralization epitopes involved in antibody-induced conformational changes of virus structure. J Virol (1994) 1.35
Isotypically restricted activation of B lymphocytes by lactic dehydrogenase virus. Eur J Immunol (1985) 1.34
Induction of interleukin-6 during human immunodeficiency virus infection. Blood (1990) 1.32
Diarrheal deaths in American children. Are they preventable? JAMA (1988) 1.31
Rotavirus infection of cultured intestinal epithelial cells induces secretion of CXC and CC chemokines. Gastroenterology (1998) 1.29
Biological and immunological characterization of a simian rotavirus SA11 variant with an altered genome segment 4. Virology (1989) 1.24
T-independent activation of B cells by vesicular stomatitis virus: no evidence for the need of a second signal. Cell Immunol (1996) 1.23
Vesicular stomatitis virus Indiana glycoprotein as a T-cell-dependent and -independent antigen. J Virol (1994) 1.14
In vivo polyclonal B-lymphocyte activation elicited by murine viruses. J Virol (1990) 1.11
Direct and indirect regulation of cytokine and cell cycle proteins by EBNA-2 during Epstein-Barr virus infection. J Virol (2001) 1.05
Human cytomegalovirus alters interleukin-6 production by endothelial cells. Blood (1994) 1.03
Analysis of host range restriction determinants in the rabbit model: comparison of homologous and heterologous rotavirus infections. J Virol (1998) 1.01
Human and bovine serotype G8 rotaviruses may be derived by reassortment. Arch Virol (1992) 1.01
T-cell independent IgM and enduring protective IgG antibodies induced by chimeric measles viruses. Nat Med (1998) 1.01
Antiviral T-cell-independent type 2 antibody responses induced in vivo in the absence of T and NK cells. Virology (2001) 1.00
Early response to rotavirus infection involves massive B cell activation. J Immunol (2002) 0.98
Retrovirus-induced target cell activation in the early phases of infection: the mouse mammary tumor virus model. J Virol (1997) 0.97
Influenza viruses as lymphocyte mitogens. II. Role of I-E molecules in B cell mitogenesis by influenza A viruses of the H2 and H6 subtypes. J Immunol (1985) 0.97
Rotavirus-specific intestinal immune response in mice assessed by enzyme-linked immunospot assay and intestinal fragment culture. Clin Diagn Lab Immunol (1994) 0.96
Comparisons of rotavirus VP7-typing monoclonal antibodies by competition binding assay. J Clin Microbiol (1992) 0.96
Sendai virus glycoproteins are T cell-dependent B cell mitogens. Infect Immun (1983) 0.95
Regulation of human B-cell activation, proliferation, and differentiation by soluble factors. J Clin Immunol (1984) 0.93
Recognition of rotavirus antigens by mouse L3T4-positive T helper cells. J Gen Virol (1994) 0.93
Murine cytomegalovirus infection-induced polyclonal B cell activation is independent of CD4+ T cells and CD40. Virology (1998) 0.92
Development of interleukin 6 and tumor necrosis factor alpha activity in nasopharyngeal secretions of infants and children during infection with respiratory syncytial virus. Clin Diagn Lab Immunol (1995) 0.90
Identification of VP7 epitopes associated with protection against human rotavirus illness or shedding in volunteers. J Virol (1992) 0.87
Characterization of serum antibody responses to natural rotavirus infections in children by VP7-specific epitope-blocking assays. J Clin Microbiol (1992) 0.86
B cell superstimulatory influenza virus activates peritoneal B cells. J Immunol (1995) 0.86
Mitogenic activity of influenza virus and haemagglutinin. Vaccine (1985) 0.85
Correlates of protection against rotavirus infection and disease. Novartis Found Symp (2001) 0.83
B lymphocytes of mice display an aberrant activation phenotype and are cell cycle arrested in G0/G1A during acute infection with Trypanosoma brucei. J Immunol (1994) 0.81
Subset of spleen lymphocytes from BALB/cCrgl mice stimulated by mouse mammary tumor virus. Cancer Res (1981) 0.80
Studies on B-cell activation in vitro. Ann Immunol (Paris) (1983) 0.76
Norovirus gastroenteritis. N Engl J Med (2009) 7.66
Norwalk virus infection and disease is associated with ABO histo-blood group type. J Infect Dis (2002) 5.09
Laboratory efforts to cultivate noroviruses. J Gen Virol (2004) 4.41
Uniformity of rotavirus strain nomenclature proposed by the Rotavirus Classification Working Group (RCWG). Arch Virol (2011) 3.87
Norovirus vaccine against experimental human Norwalk Virus illness. N Engl J Med (2011) 3.78
Norwalk virus shedding after experimental human infection. Emerg Infect Dis (2008) 3.70
Advanced antisense therapies for postexposure protection against lethal filovirus infections. Nat Med (2010) 3.25
Norwalk virus-like particle hemagglutination by binding to h histo-blood group antigens. J Virol (2003) 3.15
An immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysema. PLoS Med (2004) 3.12
Norovirus disease: changing epidemiology and host susceptibility factors. Trends Microbiol (2004) 2.83
Recommendations for the classification of group A rotaviruses using all 11 genomic RNA segments. Arch Virol (2008) 2.77
Effect of tauroursodeoxycholic acid on endoplasmic reticulum stress-induced caspase-12 activation. Hepatology (2002) 2.71
Conserved receptor-binding domains of Lake Victoria marburgvirus and Zaire ebolavirus bind a common receptor. J Biol Chem (2006) 2.56
Atomic resolution structural characterization of recognition of histo-blood group antigens by Norwalk virus. Proc Natl Acad Sci U S A (2008) 2.54
Rotavirus antigenaemia and viraemia: a common event? Lancet (2003) 2.51
Determination of the 50% human infectious dose for Norwalk virus. J Infect Dis (2013) 2.50
The epidemiologic and clinical importance of norovirus infection. Gastroenterol Clin North Am (2006) 2.49
Designing a biocontainment unit to care for patients with serious communicable diseases: a consensus statement. Biosecur Bioterror (2006) 2.43
The 3' end of Norwalk virus mRNA contains determinants that regulate the expression and stability of the viral capsid protein VP1: a novel function for the VP2 protein. J Virol (2003) 2.38
Structural requirements for the assembly of Norwalk virus-like particles. J Virol (2002) 2.38
Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization. Proc Natl Acad Sci U S A (2005) 2.35
Norwalk virus infection associates with secretor status genotyped from sera. J Med Virol (2005) 2.34
Serological correlate of protection against norovirus-induced gastroenteritis. J Infect Dis (2010) 2.21
X-ray structure of a native calicivirus: structural insights into antigenic diversity and host specificity. Proc Natl Acad Sci U S A (2006) 2.09
Intact fetal cells in maternal plasma: are they really there? Lancet (2003) 2.09
Flow cytometric analysis of circulating microparticles in plasma. Cytometry A (2010) 2.09
Rotaviruses: from pathogenesis to vaccination. Gastroenterology (2009) 2.05
Protective effect of natural rotavirus infection in an Indian birth cohort. N Engl J Med (2011) 2.04
Seasonal pulses of Marburg virus circulation in juvenile Rousettus aegyptiacus bats coincide with periods of increased risk of human infection. PLoS Pathog (2012) 2.00
Humoral, mucosal, and cellular immune responses to oral Norwalk virus-like particles in volunteers. Clin Immunol (2003) 1.89
Neonatal infection with G10P[11] rotavirus did not confer protection against subsequent rotavirus infection in a community cohort in Vellore, South India. J Infect Dis (2007) 1.83
Inter- and intragenus structural variations in caliciviruses and their functional implications. J Virol (2004) 1.79
Vaccine to confer to nonhuman primates complete protection against multistrain Ebola and Marburg virus infections. Clin Vaccine Immunol (2008) 1.78
Evolutionary trace residues in noroviruses: importance in receptor binding, antigenicity, virion assembly, and strain diversity. J Virol (2005) 1.71
Norwalk virus RNA is infectious in mammalian cells. J Virol (2007) 1.66
Cell attachment protein VP8* of a human rotavirus specifically interacts with A-type histo-blood group antigen. Nature (2012) 1.65
Norwalk virus-specific binding to oyster digestive tissues. Emerg Infect Dis (2006) 1.63
VP35 knockdown inhibits Ebola virus amplification and protects against lethal infection in mice. Antimicrob Agents Chemother (2006) 1.63
Aqp2-expressing cells give rise to renal intercalated cells. J Am Soc Nephrol (2013) 1.59
Generation of Marburg virus-like particles by co-expression of glycoprotein and matrix protein. FEMS Immunol Med Microbiol (2004) 1.58
Replication and packaging of Norwalk virus RNA in cultured mammalian cells. Proc Natl Acad Sci U S A (2005) 1.56
Detrimental effects of adenosine signaling in sickle cell disease. Nat Med (2010) 1.54
Identification of Genogroup I and Genogroup II broadly reactive epitopes on the norovirus capsid. J Virol (2005) 1.53
Structural analysis of histo-blood group antigen binding specificity in a norovirus GII.4 epidemic variant: implications for epochal evolution. J Virol (2011) 1.53
Comparative study of the epidemiology of rotavirus in children from a community-based birth cohort and a hospital in South India. J Clin Microbiol (2006) 1.51
Epidemiology of human noroviruses and updates on vaccine development. Curr Opin Gastroenterol (2014) 1.49
Rotavirus architecture at subnanometer resolution. J Virol (2008) 1.48
Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections. Vaccine (2005) 1.44
Seroepidemiology of norovirus-associated travelers' diarrhea. J Travel Med (2014) 1.43
Rotavirus viremia and extraintestinal viral infection in the neonatal rat model. J Virol (2006) 1.43
Cell-free fetal DNA in maternal blood: kinetics, source and structure. Hum Reprod Update (2004) 1.43
Vaccine-acquired rotavirus in infants with severe combined immunodeficiency. N Engl J Med (2010) 1.43
Can serum surfactant protein D or CC-chemokine ligand 18 predict outcome of interstitial lung disease in patients with early systemic sclerosis? J Rheumatol (2013) 1.43
Initial interaction of rotavirus strains with N-acetylneuraminic (sialic) acid residues on the cell surface correlates with VP4 genotype, not species of origin. J Virol (2002) 1.42
Rotavirus antigenemia in children is associated with viremia. PLoS Med (2007) 1.42
Cross-reactivity among several recombinant calicivirus virus-like particles (VLPs) with monoclonal antibodies obtained from mice immunized orally with one type of VLP. J Clin Microbiol (2002) 1.40
Burden of illness in the first 3 years of life in an Indian slum. J Trop Pediatr (2009) 1.40
Norwalk virus does not replicate in human macrophages or dendritic cells derived from the peripheral blood of susceptible humans. Virology (2010) 1.40
X-ray crystallographic structure of the Norwalk virus protease at 1.5-A resolution. J Virol (2006) 1.37
Antibody prevalence and titer to norovirus (genogroup II) correlate with secretor (FUT2) but not with ABO phenotype or Lewis (FUT3) genotype. J Infect Dis (2006) 1.32
Strain-dependent norovirus bioaccumulation in oysters. Appl Environ Microbiol (2011) 1.32
Autophagy hijacked through viroporin-activated calcium/calmodulin-dependent kinase kinase-β signaling is required for rotavirus replication. Proc Natl Acad Sci U S A (2012) 1.30
Managing potential laboratory exposure to ebola virus by using a patient biocontainment care unit. Emerg Infect Dis (2008) 1.30
Stem cell-derived human intestinal organoids as an infection model for rotaviruses. MBio (2012) 1.27
Correlation between Helicobacter pylori OipA protein expression and oipA gene switch status. J Clin Microbiol (2004) 1.27
Norwalk virus assembly and stability monitored by mass spectrometry. Mol Cell Proteomics (2010) 1.26
Chemical modifications of antisense morpholino oligomers enhance their efficacy against Ebola virus infection. Antimicrob Agents Chemother (2009) 1.26
Rotavirus: to the gut and beyond! Curr Opin Gastroenterol (2007) 1.23
Regulatory T cell expansion in HTLV-1 and strongyloidiasis co-infection is associated with reduced IL-5 responses to Strongyloides stercoralis antigen. PLoS Negl Trop Dis (2009) 1.23
Monovalent virus-like particle vaccine protects guinea pigs and nonhuman primates against infection with multiple Marburg viruses. Expert Rev Vaccines (2008) 1.23
Lack of norovirus replication and histo-blood group antigen expression in 3-dimensional intestinal epithelial cells. Emerg Infect Dis (2013) 1.23
Ebola virus uses clathrin-mediated endocytosis as an entry pathway. Virology (2010) 1.23
Serological responses to experimental Norwalk virus infection measured using a quantitative duplex time-resolved fluorescence immunoassay. Clin Vaccine Immunol (2011) 1.20
Novel structurally designed vaccine for S. aureus α-hemolysin: protection against bacteremia and pneumonia. PLoS One (2012) 1.20
Cryoelectron microscopy structures of rotavirus NSP2-NSP5 and NSP2-RNA complexes: implications for genome replication. J Virol (2006) 1.20
Analysis of Ebola virus and VLP release using an immunocapture assay. J Virol Methods (2005) 1.16
Virus nomenclature below the species level: a standardized nomenclature for laboratory animal-adapted strains and variants of viruses assigned to the family Filoviridae. Arch Virol (2013) 1.16
Integrins alpha1beta1 and alpha2beta1 are receptors for the rotavirus enterotoxin. Proc Natl Acad Sci U S A (2008) 1.15
A general method for bead-enhanced quantitation by flow cytometry. J Immunol Methods (2006) 1.15
Norwalk Virus Minor Capsid Protein VP2 Associates within the VP1 Shell Domain. J Virol (2013) 1.15
Ebola and Marburg virus-like particles activate human myeloid dendritic cells. Virology (2004) 1.13
Rotavirus disrupts calcium homeostasis by NSP4 viroporin activity. MBio (2010) 1.13
Functional CD8+ T cell responses in lethal Ebola virus infection. J Immunol (2008) 1.10
Probiotics stimulate enterocyte migration and microbial diversity in the neonatal mouse intestine. FASEB J (2012) 1.10
VLA-2 (alpha2beta1) integrin promotes rotavirus entry into cells but is not necessary for rotavirus attachment. J Virol (2002) 1.10